According to a new report published by UnivDatos Markets Insights, the monoclonal antibodies market was valued at USD 180 billion in 2021 & is expected to grow at a CAGR of 9% from 2022-2028. The analysis has been segmented into Source (Chimeric, Human, Humanized, and Murine); Indication (Oncology, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, and Others); End User...

According to a new report published by UnivDatos Markets Insights, the monoclonal antibodies market was valued at USD 180 billion in 2021 & is expected to grow at a CAGR of 9% from 2022-2028. The analysis has been segmented into Source (Chimeric, Human, Humanized, and Murine); Indication (Oncology, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, and Others); End User...

Monoclonal antibodies (mAbs) are laboratory-made proteins that are designed to mimic the immune system's ability to fight off harmful pathogens such as viruses and cancer cells. Since the approval of the first monoclonal antibody drug, Orthoclone OKT3, in 1986, monoclonal antibodies have revolutionized the treatment of various diseases, including cancer, autoimmune disorders, and infectious...

Reports and Data have published a novel report on the global Antibody Therapeutics market that offers a comprehensive overview of the market and helps investors, and users understand market dynamics and make investment plans accordingly. The report offers details about market revenue growth, market size, drivers, restraints, limitations, growth opportunities, and top companies....

The global b cell b cell antibody production market size is expected to reach USD 37.81 Billion in 2030 and register a revenue CAGR of 14.4% over the forecast period, according to the latest report by Reports and Data. Rising prevalence of infectious and bacterial diseases, increased investment to accelerate the development of novel antibiotic therapies for infectious diseases, and an...

    Rapid growth in drug discovery and development in pharmaceutical sector, and increasing use of critter models in basic and applied research are some key factors driving market revenue growth The global critter model market size is expected to reach USD 3.15 Billion in 2030 and register a revenue CAGR of 7.6% over the forecast period, according to...

The Rabies Human Monoclonal Antibody Market report provides detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global Rabies Human Monoclonal Antibody Market players, value chain optimization, trade regulations, recent developments, opportunities...

The global research antibodies market is expected to reach USD 5.33 Billion by 2027, according to a new report by Reports and Data. Rising research activities in the field of stem cells is a significant factor driving the growth of the market. Stem cells have the capability of discerning and regenerating various kinds of cells in the human body. These cells possess the potential to...